UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Development of Scalable Routes to 1‑Bicyclo[1.1.1]pentylpyrazoles

Organic process research & development, 2021-03, Vol.25 (3), p.642-647

2021

Volltextzugriff (PDF)

Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors

Bioorganic & medicinal chemistry letters, 2021-07, Vol.44, p.128082, Article 128082

2021

Volltextzugriff (PDF)

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1‑Heteroaryl‑1H‑Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16801-16817

2022

Volltextzugriff (PDF)

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1 H -Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16801-16817

2022

Volltextzugriff (PDF)

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV‑1 Protease Inhibitors

ACS medicinal chemistry letters, 2017-12, Vol.8 (12), p.1292-1297

2017

Volltextzugriff (PDF)

Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor

Bioorganic & medicinal chemistry letters, 2010-10, Vol.20 (19), p.5925-5932

2010

Volltextzugriff (PDF)

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (18), p.4715-4722

2006

Volltextzugriff (PDF)

Synthesis of the Liposidomycin Diazepanone Nucleoside

Organic letters, 2002-02, Vol.4 (4), p.603-606

2002

Volltextzugriff (PDF)

Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to Humans

Molecular endocrinology (Baltimore, Md.), 2000-01, Vol.14 (1), p.160-169

2000

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationship of novel CCR2 antagonists

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (6), p.1830-1834

2009

Volltextzugriff (PDF)

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β₃ adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (6), p.1865-1870

2011

Volltextzugriff (PDF)

Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (5), p.2156-2170

2008

Volltextzugriff (PDF)

Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists

Bioorganic & medicinal chemistry letters, 2010-03, Vol.20 (6), p.2007-2012

2010

Volltextzugriff (PDF)

Tetrahydroindolizinone NK1 antagonists

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2354-2358

2010

Volltextzugriff (PDF)

Short Synthesis of Octosyl Nucleosides

Organic letters, 2006-03, Vol.8 (7), p.1335-1337

2006

Volltextzugriff (PDF)

Assignment of the Liposidomycin Diazepanone Stereochemistry

Journal of organic chemistry, 2001-08, Vol.66 (17), p.5822-5831

2001

Volltextzugriff (PDF)

Synthesis of Griseolic Acid B by π-Face-Dependent Radical Cyclization

Organic letters, 2001-11, Vol.3 (22), p.3583-3585

2001

Volltextzugriff (PDF)

Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (14), p.3735-3739

2006

Volltextzugriff (PDF)

Tetrahydroindolizinone NK sub(1) antagonists

Bioorganic & medicinal chemistry letters, 2010-04, Vol.20 (7), p.2354-2358

2010

Volltextzugriff (PDF)

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human beta sub(3 adrenergic receptor agonists)

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (6), p.1865-1870

2011

Volltextzugriff (PDF)

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β 3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2011, Vol.21 (6), p.1865-1870

2011

Volltextzugriff (PDF)

Tetrahydroindolizinone NK 1 antagonists

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (7), p.2354-2358

2010

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Chemistry
(15)
Chemistry, Organic
(14)
Physical Sciences
(14)
Humans
(12)
Chemistry, Medicinal
(10)
Life Sciences & Biomedicine
(10)
Pharmacology & Pharmacy
(10)
Animals
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(8)
Structure-Activity Relationship
(7)
Models, Molecular
(6)
Rats
(6)
Molecular Structure
(5)
Neuropharmacology
(5)
Neurotransmitters. Neurotransmission. Receptors
(5)
Macaca Mulatta
(4)
Neurokinin-1 Receptor Antagonists
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of Scalable Routes to 1‑Bicyclo[1.1.1]pentylpyrazoles

Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors

Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1‑Heteroaryl‑1H‑Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1 H -Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV‑1 Protease Inhibitors

Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties

Synthesis of the Liposidomycin Diazepanone Nucleoside

Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to Humans

Design, synthesis, and structure–activity relationship of novel CCR2 antagonists

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β₃ adrenergic receptor agonists

Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists

Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists

Tetrahydroindolizinone NK1 antagonists

Short Synthesis of Octosyl Nucleosides

Assignment of the Liposidomycin Diazepanone Stereochemistry

Synthesis of Griseolic Acid B by π-Face-Dependent Radical Cyclization

Discovery of Vibegron: A Potent and Selective β 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists

Tetrahydroindolizinone NK sub(1) antagonists

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human beta sub(3 adrenergic receptor agonists)

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β 3 adrenergic receptor agonists

Tetrahydroindolizinone NK 1 antagonists

Suchergebnisse filtern